Yumiko Ushiyama
Hongo, 1130033, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situ.
Journal: Human pathology
Published: March 25, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.
Journal: Annals of surgical oncology
Published: January 26, 2026
Clinical Outcomes and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A Real-World Data Analysis.
Journal: World journal of oncology
Published: November 19, 2025
Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosis.
Journal: Breast cancer (Tokyo, Japan)
Published: February 04, 2025
A Case Report of Severe Thrombocytopenic Purpura during Neoadjuvant Pembrolizumab Administration for Triple-Negative Breast Cancer.
Journal: Surgical case reports
Published: October 22, 2024
A case of phyllodes tumor with rapid growth during pregnancy and lactation period: a case report.
Journal: Surgical case reports
Published: January 18, 2024
Relationship Between Daily Dose of Everolimus and Treatment Effect in Patients With Luminal HER2-negative Metastatic Breast Cancer.
Journal: Anticancer research
Published: August 29, 2023
Acute myocarditis during adjuvant therapies for breast cancer: a case report.
Journal: Surgical case reports
Published: January 24, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026